nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—Cytochrome P450 1A2 Inhibitors—Vemurafenib—skin cancer	0.583	0.807	CiPCiCtD
Amiodarone—P-Glycoprotein Inhibitors—Vemurafenib—skin cancer	0.139	0.193	CiPCiCtD
Amiodarone—CYP1A2—Imiquimod—skin cancer	0.0186	0.092	CbGbCtD
Amiodarone—CYP1A1—Dacarbazine—skin cancer	0.0175	0.0865	CbGbCtD
Amiodarone—CYP2C8—Vismodegib—skin cancer	0.0166	0.0824	CbGbCtD
Amiodarone—CYP2C19—Vismodegib—skin cancer	0.014	0.0691	CbGbCtD
Amiodarone—CYP2A6—Fluorouracil—skin cancer	0.012	0.0593	CbGbCtD
Amiodarone—CYP2C9—Vismodegib—skin cancer	0.0116	0.0575	CbGbCtD
Amiodarone—ABCB1—Vismodegib—skin cancer	0.0113	0.0558	CbGbCtD
Amiodarone—CYP1A2—Vemurafenib—skin cancer	0.0102	0.0504	CbGbCtD
Amiodarone—CYP3A4—Imiquimod—skin cancer	0.00974	0.0482	CbGbCtD
Amiodarone—CYP3A4—Temozolomide—skin cancer	0.00974	0.0482	CbGbCtD
Amiodarone—CYP2D6—Vemurafenib—skin cancer	0.00839	0.0415	CbGbCtD
Amiodarone—CYP1A2—Dacarbazine—skin cancer	0.00781	0.0386	CbGbCtD
Amiodarone—CYP3A4—Vismodegib—skin cancer	0.00675	0.0334	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.00626	0.031	CbGbCtD
Amiodarone—CYP3A7—Docetaxel—skin cancer	0.00626	0.031	CbGbCtD
Amiodarone—ABCB1—Dactinomycin—skin cancer	0.00592	0.0293	CbGbCtD
Amiodarone—CYP2C8—Fluorouracil—skin cancer	0.00591	0.0293	CbGbCtD
Amiodarone—CYP3A4—Vemurafenib—skin cancer	0.00534	0.0264	CbGbCtD
Amiodarone—CYP3A5—Docetaxel—skin cancer	0.0047	0.0232	CbGbCtD
Amiodarone—CYP1A2—Fluorouracil—skin cancer	0.00458	0.0227	CbGbCtD
Amiodarone—CYP2C9—Fluorouracil—skin cancer	0.00412	0.0204	CbGbCtD
Amiodarone—ABCB1—Docetaxel—skin cancer	0.00306	0.0151	CbGbCtD
Amiodarone—CYP3A4—Docetaxel—skin cancer	0.00183	0.00906	CbGbCtD
Amiodarone—EBP—Sorafenib—Vismodegib—skin cancer	0.00117	1	CbGdCrCtD
Amiodarone—Proparacaine—SCN10A—skin cancer	0.000847	0.367	CrCbGaD
Amiodarone—Oxybuprocaine—SCN10A—skin cancer	0.000775	0.336	CrCbGaD
Amiodarone—Cinchocaine—SCN10A—skin cancer	0.000687	0.298	CrCbGaD
Amiodarone—THRA—neck—skin cancer	0.000462	0.0694	CbGeAlD
Amiodarone—THRB—neck—skin cancer	0.000462	0.0694	CbGeAlD
Amiodarone—CACNA2D2—neck—skin cancer	0.000457	0.0687	CbGeAlD
Amiodarone—EBP—female reproductive system—skin cancer	0.000396	0.0595	CbGeAlD
Amiodarone—THRA—connective tissue—skin cancer	0.000331	0.0497	CbGeAlD
Amiodarone—CYP1A1—skin epidermis—skin cancer	0.000297	0.0446	CbGeAlD
Amiodarone—THRB—female reproductive system—skin cancer	0.000234	0.0351	CbGeAlD
Amiodarone—THRA—female reproductive system—skin cancer	0.000234	0.0351	CbGeAlD
Amiodarone—SIGMAR1—nipple—skin cancer	0.000214	0.0321	CbGeAlD
Amiodarone—THRB—head—skin cancer	0.000195	0.0293	CbGeAlD
Amiodarone—THRA—head—skin cancer	0.000195	0.0293	CbGeAlD
Amiodarone—CACNA2D2—head—skin cancer	0.000193	0.029	CbGeAlD
Amiodarone—CACNA1H—female reproductive system—skin cancer	0.000188	0.0281	CbGeAlD
Amiodarone—KCNH2—nipple—skin cancer	0.00017	0.0255	CbGeAlD
Amiodarone—ADRB1—connective tissue—skin cancer	0.000158	0.0237	CbGeAlD
Amiodarone—CYP1A2—nipple—skin cancer	0.000146	0.0219	CbGeAlD
Amiodarone—CYP1A1—nipple—skin cancer	0.000144	0.0216	CbGeAlD
Amiodarone—THRB—lymph node—skin cancer	0.000137	0.0205	CbGeAlD
Amiodarone—THRA—lymph node—skin cancer	0.000137	0.0205	CbGeAlD
Amiodarone—CACNA2D2—lymph node—skin cancer	0.000135	0.0203	CbGeAlD
Amiodarone—SIGMAR1—mammalian vulva—skin cancer	0.000125	0.0187	CbGeAlD
Amiodarone—ADRB1—female reproductive system—skin cancer	0.000111	0.0167	CbGeAlD
Amiodarone—CACNA1H—lymph node—skin cancer	0.00011	0.0165	CbGeAlD
Amiodarone—ABCB1—blood vessel—skin cancer	0.000103	0.0155	CbGeAlD
Amiodarone—CYP1A1—epithelium—skin cancer	9.68e-05	0.0145	CbGeAlD
Amiodarone—Phlebitis—Docetaxel—skin cancer	9.6e-05	0.00145	CcSEcCtD
Amiodarone—Thrombophlebitis—Docetaxel—skin cancer	9.56e-05	0.00144	CcSEcCtD
Amiodarone—Hepatitis—Dactinomycin—skin cancer	9.51e-05	0.00144	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Temozolomide—skin cancer	9.5e-05	0.00143	CcSEcCtD
Amiodarone—Flushing—Bleomycin—skin cancer	9.47e-05	0.00143	CcSEcCtD
Amiodarone—Body temperature increased—Vemurafenib—skin cancer	9.46e-05	0.00143	CcSEcCtD
Amiodarone—Pancytopenia—Fluorouracil—skin cancer	9.41e-05	0.00142	CcSEcCtD
Amiodarone—Neuropathy peripheral—Temozolomide—skin cancer	9.4e-05	0.00142	CcSEcCtD
Amiodarone—ADRB1—head—skin cancer	9.31e-05	0.014	CbGeAlD
Amiodarone—Insomnia—Imiquimod—skin cancer	9.23e-05	0.00139	CcSEcCtD
Amiodarone—CYP1A1—skin of body—skin cancer	9.21e-05	0.0138	CbGeAlD
Amiodarone—Hepatic failure—Docetaxel—skin cancer	9.21e-05	0.00139	CcSEcCtD
Amiodarone—Paraesthesia—Imiquimod—skin cancer	9.16e-05	0.00138	CcSEcCtD
Amiodarone—Cardiac failure congestive—Docetaxel—skin cancer	9.12e-05	0.00138	CcSEcCtD
Amiodarone—Dyspnoea—Imiquimod—skin cancer	9.1e-05	0.00137	CcSEcCtD
Amiodarone—Photosensitivity reaction—Fluorouracil—skin cancer	9.04e-05	0.00136	CcSEcCtD
Amiodarone—Alopecia—Bleomycin—skin cancer	9.01e-05	0.00136	CcSEcCtD
Amiodarone—Erythema multiforme—Dactinomycin—skin cancer	9e-05	0.00136	CcSEcCtD
Amiodarone—Dyspepsia—Imiquimod—skin cancer	8.98e-05	0.00136	CcSEcCtD
Amiodarone—Pneumonia—Fluorouracil—skin cancer	8.88e-05	0.00134	CcSEcCtD
Amiodarone—Erythema—Bleomycin—skin cancer	8.88e-05	0.00134	CcSEcCtD
Amiodarone—Decreased appetite—Imiquimod—skin cancer	8.87e-05	0.00134	CcSEcCtD
Amiodarone—Hot flush—Docetaxel—skin cancer	8.84e-05	0.00133	CcSEcCtD
Amiodarone—Flushing—Dactinomycin—skin cancer	8.83e-05	0.00133	CcSEcCtD
Amiodarone—Hypersensitivity—Vemurafenib—skin cancer	8.81e-05	0.00133	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Imiquimod—skin cancer	8.81e-05	0.00133	CcSEcCtD
Amiodarone—Fatigue—Imiquimod—skin cancer	8.8e-05	0.00133	CcSEcCtD
Amiodarone—Menopausal symptoms—Docetaxel—skin cancer	8.77e-05	0.00132	CcSEcCtD
Amiodarone—Atrial fibrillation—Docetaxel—skin cancer	8.73e-05	0.00132	CcSEcCtD
Amiodarone—Visual disturbance—Docetaxel—skin cancer	8.73e-05	0.00132	CcSEcCtD
Amiodarone—Pain—Imiquimod—skin cancer	8.72e-05	0.00132	CcSEcCtD
Amiodarone—Renal impairment—Docetaxel—skin cancer	8.69e-05	0.00131	CcSEcCtD
Amiodarone—Neuropathy peripheral—Fluorouracil—skin cancer	8.66e-05	0.00131	CcSEcCtD
Amiodarone—Hepatitis—Temozolomide—skin cancer	8.61e-05	0.0013	CcSEcCtD
Amiodarone—Asthenia—Vemurafenib—skin cancer	8.58e-05	0.0013	CcSEcCtD
Amiodarone—Hallucination—Temozolomide—skin cancer	8.56e-05	0.00129	CcSEcCtD
Amiodarone—KCNH2—female reproductive system—skin cancer	8.51e-05	0.0128	CbGeAlD
Amiodarone—Cardiac failure—Docetaxel—skin cancer	8.48e-05	0.00128	CcSEcCtD
Amiodarone—Pruritus—Vemurafenib—skin cancer	8.46e-05	0.00128	CcSEcCtD
Amiodarone—Alopecia—Dactinomycin—skin cancer	8.41e-05	0.00127	CcSEcCtD
Amiodarone—Feeling abnormal—Imiquimod—skin cancer	8.41e-05	0.00127	CcSEcCtD
Amiodarone—CYP1A1—mammalian vulva—skin cancer	8.4e-05	0.0126	CbGeAlD
Amiodarone—Gastrointestinal pain—Imiquimod—skin cancer	8.34e-05	0.00126	CcSEcCtD
Amiodarone—Visual impairment—Temozolomide—skin cancer	8.29e-05	0.00125	CcSEcCtD
Amiodarone—Erythema—Dactinomycin—skin cancer	8.28e-05	0.00125	CcSEcCtD
Amiodarone—Agranulocytosis—Fluorouracil—skin cancer	8.24e-05	0.00124	CcSEcCtD
Amiodarone—Ill-defined disorder—Bleomycin—skin cancer	8.24e-05	0.00124	CcSEcCtD
Amiodarone—Diarrhoea—Vemurafenib—skin cancer	8.19e-05	0.00124	CcSEcCtD
Amiodarone—Erythema multiforme—Temozolomide—skin cancer	8.14e-05	0.00123	CcSEcCtD
Amiodarone—Urticaria—Imiquimod—skin cancer	8.1e-05	0.00122	CcSEcCtD
Amiodarone—Abdominal pain—Imiquimod—skin cancer	8.06e-05	0.00122	CcSEcCtD
Amiodarone—Body temperature increased—Imiquimod—skin cancer	8.06e-05	0.00122	CcSEcCtD
Amiodarone—Tinnitus—Temozolomide—skin cancer	8.02e-05	0.00121	CcSEcCtD
Amiodarone—Malaise—Bleomycin—skin cancer	8.01e-05	0.00121	CcSEcCtD
Amiodarone—Flushing—Temozolomide—skin cancer	7.99e-05	0.00121	CcSEcCtD
Amiodarone—Dizziness—Vemurafenib—skin cancer	7.91e-05	0.00119	CcSEcCtD
Amiodarone—CYP2C8—female reproductive system—skin cancer	7.79e-05	0.0117	CbGeAlD
Amiodarone—Ataxia—Docetaxel—skin cancer	7.78e-05	0.00117	CcSEcCtD
Amiodarone—Cough—Bleomycin—skin cancer	7.75e-05	0.00117	CcSEcCtD
Amiodarone—Ill-defined disorder—Dactinomycin—skin cancer	7.68e-05	0.00116	CcSEcCtD
Amiodarone—Liver function test abnormal—Docetaxel—skin cancer	7.64e-05	0.00115	CcSEcCtD
Amiodarone—Vomiting—Vemurafenib—skin cancer	7.61e-05	0.00115	CcSEcCtD
Amiodarone—Alopecia—Temozolomide—skin cancer	7.6e-05	0.00115	CcSEcCtD
Amiodarone—Rash—Vemurafenib—skin cancer	7.54e-05	0.00114	CcSEcCtD
Amiodarone—Dermatitis—Vemurafenib—skin cancer	7.54e-05	0.00114	CcSEcCtD
Amiodarone—Hypersensitivity—Imiquimod—skin cancer	7.52e-05	0.00113	CcSEcCtD
Amiodarone—Headache—Vemurafenib—skin cancer	7.49e-05	0.00113	CcSEcCtD
Amiodarone—Erythema—Temozolomide—skin cancer	7.49e-05	0.00113	CcSEcCtD
Amiodarone—Discomfort—Bleomycin—skin cancer	7.47e-05	0.00113	CcSEcCtD
Amiodarone—Malaise—Dactinomycin—skin cancer	7.47e-05	0.00113	CcSEcCtD
Amiodarone—Toxic epidermal necrolysis—Docetaxel—skin cancer	7.45e-05	0.00112	CcSEcCtD
Amiodarone—Aspartate aminotransferase increased—Docetaxel—skin cancer	7.45e-05	0.00112	CcSEcCtD
Amiodarone—Dysgeusia—Temozolomide—skin cancer	7.34e-05	0.00111	CcSEcCtD
Amiodarone—Asthenia—Imiquimod—skin cancer	7.32e-05	0.0011	CcSEcCtD
Amiodarone—Confusional state—Bleomycin—skin cancer	7.31e-05	0.0011	CcSEcCtD
Amiodarone—Alanine aminotransferase increased—Docetaxel—skin cancer	7.3e-05	0.0011	CcSEcCtD
Amiodarone—Oedema—Bleomycin—skin cancer	7.25e-05	0.00109	CcSEcCtD
Amiodarone—Anaphylactic shock—Bleomycin—skin cancer	7.25e-05	0.00109	CcSEcCtD
Amiodarone—Back pain—Temozolomide—skin cancer	7.25e-05	0.00109	CcSEcCtD
Amiodarone—Pruritus—Imiquimod—skin cancer	7.22e-05	0.00109	CcSEcCtD
Amiodarone—Infection—Bleomycin—skin cancer	7.2e-05	0.00109	CcSEcCtD
Amiodarone—CYP1A1—female reproductive system—skin cancer	7.19e-05	0.0108	CbGeAlD
Amiodarone—KCNH2—head—skin cancer	7.11e-05	0.0107	CbGeAlD
Amiodarone—Nausea—Vemurafenib—skin cancer	7.11e-05	0.00107	CcSEcCtD
Amiodarone—Thrombocytopenia—Bleomycin—skin cancer	7.1e-05	0.00107	CcSEcCtD
Amiodarone—Arrhythmia—Fluorouracil—skin cancer	7.08e-05	0.00107	CcSEcCtD
Amiodarone—Vision blurred—Temozolomide—skin cancer	7.06e-05	0.00107	CcSEcCtD
Amiodarone—Bronchospasm—Docetaxel—skin cancer	7.03e-05	0.00106	CcSEcCtD
Amiodarone—Tremor—Temozolomide—skin cancer	7.02e-05	0.00106	CcSEcCtD
Amiodarone—Alopecia—Fluorouracil—skin cancer	7.01e-05	0.00106	CcSEcCtD
Amiodarone—Diarrhoea—Imiquimod—skin cancer	6.98e-05	0.00105	CcSEcCtD
Amiodarone—Discomfort—Dactinomycin—skin cancer	6.97e-05	0.00105	CcSEcCtD
Amiodarone—Angina pectoris—Docetaxel—skin cancer	6.96e-05	0.00105	CcSEcCtD
Amiodarone—Ill-defined disorder—Temozolomide—skin cancer	6.95e-05	0.00105	CcSEcCtD
Amiodarone—CYP2C9—female reproductive system—skin cancer	6.92e-05	0.0104	CbGeAlD
Amiodarone—Anorexia—Bleomycin—skin cancer	6.91e-05	0.00104	CcSEcCtD
Amiodarone—Erythema—Fluorouracil—skin cancer	6.9e-05	0.00104	CcSEcCtD
Amiodarone—Agitation—Temozolomide—skin cancer	6.88e-05	0.00104	CcSEcCtD
Amiodarone—Angioedema—Temozolomide—skin cancer	6.85e-05	0.00103	CcSEcCtD
Amiodarone—Pancytopenia—Docetaxel—skin cancer	6.79e-05	0.00102	CcSEcCtD
Amiodarone—Hypotension—Bleomycin—skin cancer	6.77e-05	0.00102	CcSEcCtD
Amiodarone—Oedema—Dactinomycin—skin cancer	6.76e-05	0.00102	CcSEcCtD
Amiodarone—Malaise—Temozolomide—skin cancer	6.76e-05	0.00102	CcSEcCtD
Amiodarone—Dizziness—Imiquimod—skin cancer	6.75e-05	0.00102	CcSEcCtD
Amiodarone—Vertigo—Temozolomide—skin cancer	6.73e-05	0.00102	CcSEcCtD
Amiodarone—Infection—Dactinomycin—skin cancer	6.72e-05	0.00101	CcSEcCtD
Amiodarone—Neutropenia—Docetaxel—skin cancer	6.69e-05	0.00101	CcSEcCtD
Amiodarone—Thrombocytopenia—Dactinomycin—skin cancer	6.62e-05	0.000999	CcSEcCtD
Amiodarone—Cough—Temozolomide—skin cancer	6.54e-05	0.000986	CcSEcCtD
Amiodarone—Paraesthesia—Bleomycin—skin cancer	6.51e-05	0.000982	CcSEcCtD
Amiodarone—Weight increased—Docetaxel—skin cancer	6.51e-05	0.000982	CcSEcCtD
Amiodarone—Vision blurred—Fluorouracil—skin cancer	6.5e-05	0.000982	CcSEcCtD
Amiodarone—Vomiting—Imiquimod—skin cancer	6.49e-05	0.000979	CcSEcCtD
Amiodarone—Weight decreased—Docetaxel—skin cancer	6.47e-05	0.000976	CcSEcCtD
Amiodarone—Dyspnoea—Bleomycin—skin cancer	6.46e-05	0.000975	CcSEcCtD
Amiodarone—Anorexia—Dactinomycin—skin cancer	6.44e-05	0.000972	CcSEcCtD
Amiodarone—Rash—Imiquimod—skin cancer	6.43e-05	0.000971	CcSEcCtD
Amiodarone—Dermatitis—Imiquimod—skin cancer	6.43e-05	0.00097	CcSEcCtD
Amiodarone—Pneumonia—Docetaxel—skin cancer	6.41e-05	0.000967	CcSEcCtD
Amiodarone—Headache—Imiquimod—skin cancer	6.39e-05	0.000964	CcSEcCtD
Amiodarone—Anxiety—Temozolomide—skin cancer	6.36e-05	0.000959	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Docetaxel—skin cancer	6.32e-05	0.000954	CcSEcCtD
Amiodarone—Discomfort—Temozolomide—skin cancer	6.3e-05	0.000951	CcSEcCtD
Amiodarone—Decreased appetite—Bleomycin—skin cancer	6.3e-05	0.000951	CcSEcCtD
Amiodarone—Renal failure—Docetaxel—skin cancer	6.27e-05	0.000946	CcSEcCtD
Amiodarone—SIGMAR1—lymph node—skin cancer	6.26e-05	0.00939	CbGeAlD
Amiodarone—Neuropathy peripheral—Docetaxel—skin cancer	6.25e-05	0.000943	CcSEcCtD
Amiodarone—Dry mouth—Temozolomide—skin cancer	6.24e-05	0.000941	CcSEcCtD
Amiodarone—Jaundice—Docetaxel—skin cancer	6.21e-05	0.000938	CcSEcCtD
Amiodarone—Pain—Bleomycin—skin cancer	6.2e-05	0.000935	CcSEcCtD
Amiodarone—Confusional state—Temozolomide—skin cancer	6.16e-05	0.00093	CcSEcCtD
Amiodarone—Anaphylactic shock—Temozolomide—skin cancer	6.11e-05	0.000923	CcSEcCtD
Amiodarone—Oedema—Temozolomide—skin cancer	6.11e-05	0.000923	CcSEcCtD
Amiodarone—Infection—Temozolomide—skin cancer	6.07e-05	0.000916	CcSEcCtD
Amiodarone—Nausea—Imiquimod—skin cancer	6.06e-05	0.000914	CcSEcCtD
Amiodarone—CYP1A1—head—skin cancer	6.01e-05	0.00902	CbGeAlD
Amiodarone—Thrombocytopenia—Temozolomide—skin cancer	5.99e-05	0.000903	CcSEcCtD
Amiodarone—Feeling abnormal—Bleomycin—skin cancer	5.97e-05	0.000901	CcSEcCtD
Amiodarone—Agranulocytosis—Docetaxel—skin cancer	5.95e-05	0.000898	CcSEcCtD
Amiodarone—Skin disorder—Temozolomide—skin cancer	5.94e-05	0.000896	CcSEcCtD
Amiodarone—Hyperhidrosis—Temozolomide—skin cancer	5.91e-05	0.000892	CcSEcCtD
Amiodarone—Decreased appetite—Dactinomycin—skin cancer	5.88e-05	0.000887	CcSEcCtD
Amiodarone—Fatigue—Dactinomycin—skin cancer	5.83e-05	0.000879	CcSEcCtD
Amiodarone—Anorexia—Temozolomide—skin cancer	5.83e-05	0.000879	CcSEcCtD
Amiodarone—Discomfort—Fluorouracil—skin cancer	5.81e-05	0.000876	CcSEcCtD
Amiodarone—Pain—Dactinomycin—skin cancer	5.78e-05	0.000872	CcSEcCtD
Amiodarone—Urticaria—Bleomycin—skin cancer	5.76e-05	0.000869	CcSEcCtD
Amiodarone—Body temperature increased—Bleomycin—skin cancer	5.73e-05	0.000865	CcSEcCtD
Amiodarone—Hepatitis—Docetaxel—skin cancer	5.72e-05	0.000864	CcSEcCtD
Amiodarone—Confusional state—Fluorouracil—skin cancer	5.68e-05	0.000857	CcSEcCtD
Amiodarone—Anaphylactic shock—Fluorouracil—skin cancer	5.63e-05	0.00085	CcSEcCtD
Amiodarone—Oedema—Fluorouracil—skin cancer	5.63e-05	0.00085	CcSEcCtD
Amiodarone—Infection—Fluorouracil—skin cancer	5.6e-05	0.000844	CcSEcCtD
Amiodarone—Feeling abnormal—Dactinomycin—skin cancer	5.57e-05	0.00084	CcSEcCtD
Amiodarone—Insomnia—Temozolomide—skin cancer	5.53e-05	0.000834	CcSEcCtD
Amiodarone—Gastrointestinal pain—Dactinomycin—skin cancer	5.53e-05	0.000834	CcSEcCtD
Amiodarone—Thrombocytopenia—Fluorouracil—skin cancer	5.52e-05	0.000832	CcSEcCtD
Amiodarone—Visual impairment—Docetaxel—skin cancer	5.52e-05	0.000832	CcSEcCtD
Amiodarone—Tachycardia—Fluorouracil—skin cancer	5.5e-05	0.00083	CcSEcCtD
Amiodarone—Paraesthesia—Temozolomide—skin cancer	5.49e-05	0.000828	CcSEcCtD
Amiodarone—Dyspnoea—Temozolomide—skin cancer	5.45e-05	0.000822	CcSEcCtD
Amiodarone—Erythema multiforme—Docetaxel—skin cancer	5.41e-05	0.000816	CcSEcCtD
Amiodarone—Dyspepsia—Temozolomide—skin cancer	5.38e-05	0.000812	CcSEcCtD
Amiodarone—Anorexia—Fluorouracil—skin cancer	5.37e-05	0.00081	CcSEcCtD
Amiodarone—Body temperature increased—Dactinomycin—skin cancer	5.34e-05	0.000806	CcSEcCtD
Amiodarone—Abdominal pain—Dactinomycin—skin cancer	5.34e-05	0.000806	CcSEcCtD
Amiodarone—Hypersensitivity—Bleomycin—skin cancer	5.34e-05	0.000806	CcSEcCtD
Amiodarone—Decreased appetite—Temozolomide—skin cancer	5.31e-05	0.000802	CcSEcCtD
Amiodarone—Flushing—Docetaxel—skin cancer	5.31e-05	0.000801	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Temozolomide—skin cancer	5.28e-05	0.000796	CcSEcCtD
Amiodarone—CYP3A4—female reproductive system—skin cancer	5.28e-05	0.00792	CbGeAlD
Amiodarone—Fatigue—Temozolomide—skin cancer	5.27e-05	0.000795	CcSEcCtD
Amiodarone—Hypotension—Fluorouracil—skin cancer	5.26e-05	0.000794	CcSEcCtD
Amiodarone—Constipation—Temozolomide—skin cancer	5.23e-05	0.000789	CcSEcCtD
Amiodarone—Pain—Temozolomide—skin cancer	5.23e-05	0.000789	CcSEcCtD
Amiodarone—Asthenia—Bleomycin—skin cancer	5.2e-05	0.000785	CcSEcCtD
Amiodarone—CYP2D6—female reproductive system—skin cancer	5.19e-05	0.00779	CbGeAlD
Amiodarone—Pruritus—Bleomycin—skin cancer	5.13e-05	0.000774	CcSEcCtD
Amiodarone—Arrhythmia—Docetaxel—skin cancer	5.11e-05	0.000771	CcSEcCtD
Amiodarone—Insomnia—Fluorouracil—skin cancer	5.09e-05	0.000769	CcSEcCtD
Amiodarone—Paraesthesia—Fluorouracil—skin cancer	5.06e-05	0.000763	CcSEcCtD
Amiodarone—Alopecia—Docetaxel—skin cancer	5.06e-05	0.000763	CcSEcCtD
Amiodarone—Feeling abnormal—Temozolomide—skin cancer	5.04e-05	0.00076	CcSEcCtD
Amiodarone—ABCB1—epithelium—skin cancer	5.03e-05	0.00755	CbGeAlD
Amiodarone—Dyspnoea—Fluorouracil—skin cancer	5.02e-05	0.000758	CcSEcCtD
Amiodarone—Gastrointestinal pain—Temozolomide—skin cancer	5e-05	0.000754	CcSEcCtD
Amiodarone—Erythema—Docetaxel—skin cancer	4.98e-05	0.000752	CcSEcCtD
Amiodarone—KCNH2—lymph node—skin cancer	4.98e-05	0.00747	CbGeAlD
Amiodarone—Hypersensitivity—Dactinomycin—skin cancer	4.98e-05	0.000751	CcSEcCtD
Amiodarone—Dyspepsia—Fluorouracil—skin cancer	4.96e-05	0.000748	CcSEcCtD
Amiodarone—Decreased appetite—Fluorouracil—skin cancer	4.9e-05	0.000739	CcSEcCtD
Amiodarone—Dysgeusia—Docetaxel—skin cancer	4.88e-05	0.000736	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Fluorouracil—skin cancer	4.86e-05	0.000734	CcSEcCtD
Amiodarone—Urticaria—Temozolomide—skin cancer	4.86e-05	0.000733	CcSEcCtD
Amiodarone—Asthenia—Dactinomycin—skin cancer	4.85e-05	0.000732	CcSEcCtD
Amiodarone—Body temperature increased—Temozolomide—skin cancer	4.83e-05	0.000729	CcSEcCtD
Amiodarone—Abdominal pain—Temozolomide—skin cancer	4.83e-05	0.000729	CcSEcCtD
Amiodarone—Back pain—Docetaxel—skin cancer	4.82e-05	0.000727	CcSEcCtD
Amiodarone—Pain—Fluorouracil—skin cancer	4.82e-05	0.000727	CcSEcCtD
Amiodarone—Feeling abnormal—Fluorouracil—skin cancer	4.64e-05	0.0007	CcSEcCtD
Amiodarone—Diarrhoea—Dactinomycin—skin cancer	4.62e-05	0.000698	CcSEcCtD
Amiodarone—Vomiting—Bleomycin—skin cancer	4.61e-05	0.000695	CcSEcCtD
Amiodarone—Rash—Bleomycin—skin cancer	4.57e-05	0.00069	CcSEcCtD
Amiodarone—Dermatitis—Bleomycin—skin cancer	4.57e-05	0.000689	CcSEcCtD
Amiodarone—Hypersensitivity—Temozolomide—skin cancer	4.5e-05	0.00068	CcSEcCtD
Amiodarone—Urticaria—Fluorouracil—skin cancer	4.48e-05	0.000675	CcSEcCtD
Amiodarone—Body temperature increased—Fluorouracil—skin cancer	4.45e-05	0.000672	CcSEcCtD
Amiodarone—Asthenia—Temozolomide—skin cancer	4.39e-05	0.000662	CcSEcCtD
Amiodarone—ABCB1—mammalian vulva—skin cancer	4.36e-05	0.00655	CbGeAlD
Amiodarone—Cough—Docetaxel—skin cancer	4.35e-05	0.000656	CcSEcCtD
Amiodarone—CYP2D6—head—skin cancer	4.34e-05	0.00651	CbGeAlD
Amiodarone—Pruritus—Temozolomide—skin cancer	4.33e-05	0.000653	CcSEcCtD
Amiodarone—Nausea—Bleomycin—skin cancer	4.31e-05	0.00065	CcSEcCtD
Amiodarone—Vomiting—Dactinomycin—skin cancer	4.3e-05	0.000648	CcSEcCtD
Amiodarone—Rash—Dactinomycin—skin cancer	4.26e-05	0.000643	CcSEcCtD
Amiodarone—CYP1A1—lymph node—skin cancer	4.21e-05	0.00631	CbGeAlD
Amiodarone—Diarrhoea—Temozolomide—skin cancer	4.18e-05	0.000631	CcSEcCtD
Amiodarone—Hypersensitivity—Fluorouracil—skin cancer	4.15e-05	0.000626	CcSEcCtD
Amiodarone—Dry mouth—Docetaxel—skin cancer	4.15e-05	0.000626	CcSEcCtD
Amiodarone—Confusional state—Docetaxel—skin cancer	4.1e-05	0.000619	CcSEcCtD
Amiodarone—Oedema—Docetaxel—skin cancer	4.07e-05	0.000613	CcSEcCtD
Amiodarone—Anaphylactic shock—Docetaxel—skin cancer	4.07e-05	0.000613	CcSEcCtD
Amiodarone—Dizziness—Temozolomide—skin cancer	4.04e-05	0.00061	CcSEcCtD
Amiodarone—Infection—Docetaxel—skin cancer	4.04e-05	0.000609	CcSEcCtD
Amiodarone—Nausea—Dactinomycin—skin cancer	4.02e-05	0.000606	CcSEcCtD
Amiodarone—Shock—Docetaxel—skin cancer	4e-05	0.000604	CcSEcCtD
Amiodarone—Pruritus—Fluorouracil—skin cancer	3.99e-05	0.000601	CcSEcCtD
Amiodarone—Thrombocytopenia—Docetaxel—skin cancer	3.98e-05	0.000601	CcSEcCtD
Amiodarone—Tachycardia—Docetaxel—skin cancer	3.97e-05	0.000599	CcSEcCtD
Amiodarone—Skin disorder—Docetaxel—skin cancer	3.95e-05	0.000596	CcSEcCtD
Amiodarone—Vomiting—Temozolomide—skin cancer	3.89e-05	0.000587	CcSEcCtD
Amiodarone—Anorexia—Docetaxel—skin cancer	3.88e-05	0.000585	CcSEcCtD
Amiodarone—ABCB1—lymphoid tissue—skin cancer	3.87e-05	0.00581	CbGeAlD
Amiodarone—Rash—Temozolomide—skin cancer	3.85e-05	0.000582	CcSEcCtD
Amiodarone—Diarrhoea—Fluorouracil—skin cancer	3.85e-05	0.000582	CcSEcCtD
Amiodarone—Dermatitis—Temozolomide—skin cancer	3.85e-05	0.000581	CcSEcCtD
Amiodarone—Headache—Temozolomide—skin cancer	3.83e-05	0.000578	CcSEcCtD
Amiodarone—Hypotension—Docetaxel—skin cancer	3.8e-05	0.000573	CcSEcCtD
Amiodarone—ABCB1—female reproductive system—skin cancer	3.73e-05	0.00561	CbGeAlD
Amiodarone—Dizziness—Fluorouracil—skin cancer	3.73e-05	0.000562	CcSEcCtD
Amiodarone—Insomnia—Docetaxel—skin cancer	3.68e-05	0.000555	CcSEcCtD
Amiodarone—Paraesthesia—Docetaxel—skin cancer	3.65e-05	0.000551	CcSEcCtD
Amiodarone—Nausea—Temozolomide—skin cancer	3.63e-05	0.000548	CcSEcCtD
Amiodarone—Dyspnoea—Docetaxel—skin cancer	3.62e-05	0.000547	CcSEcCtD
Amiodarone—Vomiting—Fluorouracil—skin cancer	3.58e-05	0.00054	CcSEcCtD
Amiodarone—Dyspepsia—Docetaxel—skin cancer	3.58e-05	0.00054	CcSEcCtD
Amiodarone—Rash—Fluorouracil—skin cancer	3.55e-05	0.000536	CcSEcCtD
Amiodarone—Dermatitis—Fluorouracil—skin cancer	3.55e-05	0.000535	CcSEcCtD
Amiodarone—Decreased appetite—Docetaxel—skin cancer	3.53e-05	0.000533	CcSEcCtD
Amiodarone—Headache—Fluorouracil—skin cancer	3.53e-05	0.000532	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Docetaxel—skin cancer	3.51e-05	0.00053	CcSEcCtD
Amiodarone—Fatigue—Docetaxel—skin cancer	3.51e-05	0.000529	CcSEcCtD
Amiodarone—Pain—Docetaxel—skin cancer	3.48e-05	0.000525	CcSEcCtD
Amiodarone—Constipation—Docetaxel—skin cancer	3.48e-05	0.000525	CcSEcCtD
Amiodarone—Feeling abnormal—Docetaxel—skin cancer	3.35e-05	0.000506	CcSEcCtD
Amiodarone—Nausea—Fluorouracil—skin cancer	3.35e-05	0.000505	CcSEcCtD
Amiodarone—Gastrointestinal pain—Docetaxel—skin cancer	3.32e-05	0.000502	CcSEcCtD
Amiodarone—Abdominal pain—Docetaxel—skin cancer	3.21e-05	0.000485	CcSEcCtD
Amiodarone—Body temperature increased—Docetaxel—skin cancer	3.21e-05	0.000485	CcSEcCtD
Amiodarone—ABCB1—head—skin cancer	3.12e-05	0.00468	CbGeAlD
Amiodarone—Hypersensitivity—Docetaxel—skin cancer	3e-05	0.000452	CcSEcCtD
Amiodarone—Asthenia—Docetaxel—skin cancer	2.92e-05	0.00044	CcSEcCtD
Amiodarone—Pruritus—Docetaxel—skin cancer	2.88e-05	0.000434	CcSEcCtD
Amiodarone—Diarrhoea—Docetaxel—skin cancer	2.78e-05	0.00042	CcSEcCtD
Amiodarone—Dizziness—Docetaxel—skin cancer	2.69e-05	0.000406	CcSEcCtD
Amiodarone—Vomiting—Docetaxel—skin cancer	2.59e-05	0.00039	CcSEcCtD
Amiodarone—Rash—Docetaxel—skin cancer	2.56e-05	0.000387	CcSEcCtD
Amiodarone—Dermatitis—Docetaxel—skin cancer	2.56e-05	0.000386	CcSEcCtD
Amiodarone—Headache—Docetaxel—skin cancer	2.55e-05	0.000384	CcSEcCtD
Amiodarone—Nausea—Docetaxel—skin cancer	2.42e-05	0.000364	CcSEcCtD
Amiodarone—ABCB1—lymph node—skin cancer	2.18e-05	0.00328	CbGeAlD
